The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Current understanding of interactions between nanoparticles and the immune system
Open accessAbstract
The delivery of drugs, antigens, and imaging agents benefits from using nanotechnology-based carriers. The successful translation of nanoformulations to the clinic involves thorough assessment of their safety profiles, which, among other endpoints, includes evaluation of immunotoxicity. The past decade of research focusing on nanoparticle interaction with the immune system has been fruitful in terms of understanding the basics of nanoparticle immunocompatibility, developing a bioanalytical infrastructure to screen for nanoparticle-mediated immune reactions, beginning to uncover the mechanisms of nanoparticle immunotoxicity, and utilizing current knowledge about the structure–activity relationship between nanoparticles’ physicochemical properties and their effects on the immune system to guide safe drug delivery. In the present review, we focus on the most prominent pieces of the nanoparticle–immune system puzzle and discuss the achievements, disappointments, and lessons learned over the past 15 years of research on the immunotoxicity of engineered nanomaterials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823 · cited 1×
“…to the initial understanding of the interactions between nanoparticles and the immune system and created a framework for stimulating discussions in the area of nano-immunotoxicology (Dobrovolskaia and McNeil, 2007; Marx, 2008; Dobrovolskaia et al., 2009a; Pantic, 2011; Smith et al., 2013).”
BackgroundSelf-citationExploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Roy, K., Mao, H.-Q., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation
Kagan, V. E., Konduru, N. V., Feng, W., Allen, B. L., Conroy, J., Volkov, Y., Vlasova, I. I., Belikova, N. A., Yanamala, N., Kapralov, A., et al. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.44 · Cited by 794
Self-citationApplications of nanotechnology for immunology
Smith, D. M., Simon, J. K., & Baker Jr, J. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3488 · Cited by 767
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Dobrovolskaia, M. A., Patri, A. K., Zheng, J., Clogston, J. D., Ayub, N., Aggarwal, P., Neun, B. W., Hall, J. B., & McNeil, S. E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.001 · Cited by 679
Self-citationSize-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Fletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Levin, A. A. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00140-2 · Cited by 438
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Complement activation and protein adsorption by carbon nanotubes
SALVADORMORALES, C., FLAHAUT, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.02.006 · Cited by 434
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Making carbon nanotubes biocompatible and biodegradable
Bianco, A., Kostarelos, K., & Prato, M. (2011) · Chemical Communications · doi:10.1039/c1cc13011k · Cited by 384
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Self-citationGene vaccination: plasmid DNA is more than just a blueprint
Tighe, H., Corr, M., Roman, M., & Raz, E. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01201-2 · Cited by 352
Differential plasma protein binding to metal oxide nanoparticles
Deng, Z. J., Mortimer, G., Schiller, T., Musumeci, A., Martin, D., & Minchin, R. F. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/45/455101 · Cited by 337
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Protracted elimination of gold nanoparticles from mouse liver
Sadauskas, E., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., & Wallin, H. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.11.002 · Cited by 328
Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice
Mitchell, L. A., Lauer, F. T., Burchiel, S. W., & McDonald, J. D. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.151 · Cited by 324
Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Villanueva, A., Cañete, M., Roca, A. G., Calero, M., Veintemillas-Verdaguer, S., Serna, C. J., del Puerto Morales, M., & Miranda, R. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/11/115103 · Cited by 299
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Mottram, P. L., Leong, D., Crimeen-Irwin, B., Gloster, S., Xiang, S. D., Meanger, J., Ghildyal, R., Vardaxis, N., & Plebanski, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060096p · Cited by 296
Thiele, L., Rothen-Rutishauser, B., Jilek, S., Wunderli-Allenspach, H., Merkle, H. P., & Walter, E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00412-6 · Cited by 281
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Fullerene Nanomaterials Inhibit the Allergic Response
Ryan, J. J., Bateman, H. R., Stover, A., Gomez, G., Norton, S. K., Zhao, W., Schwartz, L. B., Lenk, R., & Kepley, C. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.665 · Cited by 273
Crist, R. M., Grossman, J. H., Patri, A. K., Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D., & McNeil, S. E. (2013) · Integrative Biology · doi:10.1039/c2ib20117h · Cited by 265
Self-citationNatural zeolite clinoptilolite: new adjuvant in anticancer therapy
Pavelić, K., Hadžija, M., Bedrica, L., Pavelić, J., Ðikić, I., Katić, M., Kralj, M., Bosnar, M. H., Kapitanović, S., Poljak-Blaži, M., et al. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000176 · Cited by 255
Weiszhár, Z., Czúcz, J., Révész, C., Rosivall, L., Szebeni, J., & Rozsnyay, Z. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.016 · Cited by 248
Detoxification of Gold Nanorods by Treatment with Polystyrenesulfonate
Leonov, A. P., Zheng, J., Clogston, J. D., Stern, S. T., Patri, A. K., & Wei, A. (2008) · ACS Nano · doi:10.1021/nn800466c · Cited by 247
C60andC70fullerenes and potassium fullerides
Benning, P. J., Poirier, D. M., Ohno, T. R., Chen, Y., Jost, M. B., Stepniak, F., Kroll, G. H., Weaver, J. H., Fure, J., & Smalley, R. E. (1992) · Physical Review B · doi:10.1103/physrevb.45.6899 · Cited by 246
Long-acting injectable antiretrovirals for HIV treatment and prevention
Spreen, W. R., Margolis, D. A., & Pottage, J. C. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000002 · Cited by 246
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
A concise review of carbon nanotube's toxicology
Madani, S. Y., Mandel, A., & Seifalian, A. M. (2013) · Nano Reviews · doi:10.3402/nano.v4i0.21521 · Cited by 237
Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines
Little, S. R., Lynn, D. M., Ge, Q., Anderson, D. G., Puram, S. V., Chen, J., Eisen, H. N., & Langer, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403549101 · Cited by 227
Li, S., Wu, S.-P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R., & Huang, L. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l796 · Cited by 225
Baert, L., van ‘t Klooster, G., Dries, W., François, M., Wouters, A., Basstanie, E., Iterbeke, K., Stappers, F., Stevens, P., Schueller, L., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.006 · Cited by 224
Dobrovolskaia, M. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.056 · Cited by 221
Self-citationThe NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine
Baron, L., Gombault, A., Fanny, M., Villeret, B., Savigny, F., Guillou, N., Panek, C., Le Bert, M., Lagente, V, Rassendren, F., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.576 · Cited by 220
Aoyama, Y., Kanamori, T., Nakai, T., Sasaki, T., Horiuchi, S., Sando, S., & Niidome, T. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029608t · Cited by 216
An integrated approach for the in vitro dosimetry of engineered nanomaterials
Cohen, J. M., Teeguarden, J. G., & Demokritou, P. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-20 · Cited by 210
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Cationic PAMAM Dendrimers Aggressively Initiate Blood Clot Formation
Jones, C. F., Campbell, R. A., Brooks, A. E., Assemi, S., Tadjiki, S., Thiagarajan, G., Mulcock, C., Weyrich, A. S., Brooks, B. D., Ghandehari, H., et al. (2012) · ACS Nano · doi:10.1021/nn303472r · Cited by 207
Italia, J. L., Bhatt, D. K., Bhardwaj, V., Tikoo, K., & Kumar, M. N. V. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.004 · Cited by 203
Molecular Interaction of Poly(acrylic acid) Gold Nanoparticles with Human Fibrinogen
Deng, Z. J., Liang, M., Toth, I., Monteiro, M. J., & Minchin, R. F. (2012) · ACS Nano · doi:10.1021/nn3029953 · Cited by 203
Toraya-Brown, S., Sheen, M. R., Zhang, P., Chen, L., Baird, J. R., Demidenko, E., Turk, M. J., Hoopes, P. J., Conejo-Garcia, J. R., & Fiering, S. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.01.011 · Cited by 193
Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060367 · Cited by 190
Agashe, H. B., Dutta, T., Garg, M., & Jain, N. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.11.0010 · Cited by 185
Thiele, L., Merkle, H. P., & Walter, E. (2003) · Pharmaceutical Research · doi:10.1023/a:1022271020390 · Cited by 183
Nakai, T., Kanamori, T., Sando, S., & Aoyama, Y. (2003) · Journal of the American Chemical Society · doi:10.1021/ja035636f · Cited by 174
Shvedova, A. A., Kapralov, A. A., Feng, W. H., Kisin, E. R., Murray, A. R., Mercer, R. R., St. Croix, C. M., Lang, M. A., Watkins, S. C., Konduru, N. V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030923 · Cited by 173
Self-citationTeo, P. Y., Yang, C., Whilding, L. M., Parente‐Pereira, A. C., Maher, J., George, A. J. T., Hedrick, J. L., Yang, Y. Y., & Ghaem‐Maghami, S. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500089 · Cited by 172
Dobrovolskaia, M. A., Neun, B. W., Man, S., Ye, X., Hansen, M., Patri, A. K., Crist, R. M., & McNeil, S. E. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.01.009 · Cited by 169
Self-citationSize and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K., Thiagarajan, G., Herd, H., Price, R., Bauer, H., Hubbard, D., Burckle, A., Sadekar, S., Yu, T., Anwar, A., et al. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages
Tsai, C.-Y., Lu, S.-L., Hu, C.-W., Yeh, C., Lee, G., & Lei, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100344 · Cited by 163
Higaki, M., Ishihara, T., Izumo, N., Takatsu, M., & Mizushima, Y. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030759 · Cited by 153
Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Minigo, G., Scholzen, A., Tang, C. K., Hanley, J. C., Kalkanidis, M., Pietersz, G. A., Apostolopoulos, V., & Plebanski, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.086 · Cited by 151
Inoue, K., Takano, H., Yanagisawa, R., Hirano, S., Sakurai, M., Shimada, A., & Yoshikawa, T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8903 · Cited by 150
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150
Nanovaccines and their mode of action
Zaman, M., Good, M. F., & Tóth, I. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.014 · Cited by 148
Deng, Z. J., Liang, M., Tóth, I., Monteiro, M. J., & Minchin, R. F. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.655342 · Cited by 146
Lung Macrophages “Digest” Carbon Nanotubes Using a Superoxide/Peroxynitrite Oxidative Pathway
Kagan, V. E., Kapralov, A. A., Croix, C. M. S., Watkins, S. C., Kisin, E. R., Kotchey, G. P., Balasubramanian, K., Vlasova, I. I., Yu, J., Kim, K., et al. (2014) · ACS Nano · doi:10.1021/nn406484b · Cited by 145
Self-citationCationic PAMAM Dendrimers Disrupt Key Platelet Functions
Jones, C. F., Campbell, R. A., Franks, Z. G., Gibson, C. C., Thiagarajan, G., Vieira‐de‐Abreu, A., Sukavaneshvar, S., Mohammad, S., Li, D. Y., Ghandehari, H., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2006054 · Cited by 138
McHugh, M. D., Park, J. Y., Uhrich, R., Gao, W., Horwitz, D. A., & Fahmy, T. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.003 · Cited by 129
Progress in antiretroviral drug delivery using nanotechnology
Rohan, L. C., & Mallipeddi (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s7681 · Cited by 122
Stefaniak, A. B., Hackley, V. A., Roebben, G., Ehara, K., Hankin, S., Postek, M. T., Lynch, I., Fu, W.-E., Linsinger, T. P. J., & Thünemann, A. F. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.739664 · Cited by 121
Senapati, V. A., Kumar, A., Gupta, G. S., Pandey, A. K., & Dhawan, A. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.06.018 · Cited by 119
Jilek, S., Merkle, H. P., & Walter, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.010 · Cited by 119
Immunosuppressive and anti‐inflammatory properties of engineered nanomaterials
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12722 · Cited by 118
Self-citationShah, M. S., Edman, M. C., Janga, S. R., Shi, P., Dhandhukia, J. P., Liu, S., Louie, S. G., Rodgers, K. E., MacKay, J. A., & Hamm‐Alvarez, S. F. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.016 · Cited by 117
Interaction of Nanoparticles with Immunocompetent Cells: Nanosafety Considerations
Boraschi, D., Costantino, L., & Italiani, P. (2011) · Nanomedicine · doi:10.2217/nnm.11.169 · Cited by 116
Particle size and activation threshold: a new dimension of danger signaling
Rettig, L., Haen, S. P., Bittermann, A. G., von Boehmer, L., Fontecedro, A. C., Krämer, S. D., Knuth, A. K., & Pascolo, S. (2010) · Blood · doi:10.1182/blood-2009-11-247817 · Cited by 115
Macrophage Scavenger Receptor A Mediates The Uptake of Gold Colloids by Macrophages In Vitro
França, Â., Aggarwal, P., Barsov, E. V., Kozlov, S., Dobrovolskaia, M. A., & González‐Fernández, Á. (2011) · Nanomedicine · doi:10.2217/nnm.11.41 · Cited by 111
Self-citationRosenberg, A. S., Verthelyi, D. I., & Cherney, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23244 · Cited by 103
Lipson, E. J., Sharfman, W. H., Chen, S., McMiller, T. L., Pritchard, T. S., Salas, J. T., Sartorius-Mergenthaler, S., Freed, I., Ravi, S., Wang, H., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0572-3 · Cited by 100
Immunotoxicity of Nanoparticles
Petrarca, C., Mangifesta, R., & Giampaolo, L. D. (2020) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-15-4735-5_6 · Cited by 98
Schöll, I., Weissenböck, A., Förster‐Waldl, E., Untersmayr, E., Walter, F., Willheim, M., Boltz‐Nitulescu, G., Scheiner, O., Gabor, F., & Jensen‐Jarolim, E. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01884.x · Cited by 95 · cited 1×
“…anhydride) nanoparticles, and dendrosomes were used to suppress type I and type II reactions to environmental and food allergens (Royet al., 1999; Scholl et al., 2004; Balenga et al., 2006; Gomez et al., 2007; Gomez et al., 2008), while synthetic peptide dendrimers were reported to block…”
MethodXiang, S. D., Selomulya, C., Ho, J., Apostolopoulos, V., & Plebanski, M. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.88 · Cited by 93
Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
Song, G. K., Wu, H., Yoshino, K., & Zamboni, W. C. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2012.655285 · Cited by 90
Polylactide‐cyclosporin A nanoparticles for targeted immunosuppression
Azzi, J. R., Tang, L., Moore, R. F., Tong, R., Haddad, N. E., Akiyoshi, T., Mfarrej, B. G., Yang, S., Jurewicz, M. M., Ichimura, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154690 · Cited by 89
Root Cause Analysis of Tungsten-Induced Protein Aggregation in Pre-filled Syringes.
Liu, W., Swift, R., Torraca, G., Nashed-Samuel, Y., Wen, Z., Jiang, Y., Vance, A., Mire‐Sluis, A. R., Freund, E., Davis, J. L., et al. (2010) · PubMed · Cited by 84
Lymphatic system: a prospective area for advanced targeting of particulate drug carriers
Singh, I., Swami, R., Khan, W., & Sistla, R. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866088 · Cited by 83
Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens
Gómez, S., Gamazo, C., Román, B. S., Ferrer, M., Sanz, M. L., & Irache, J. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.020 · Cited by 83
Fifis, T., Mottram, P. L., Bogdanoska, V., Hanley, J. C., & Plebanski, M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.022 · Cited by 81
Park, J. S., Yang, H. N., Jeon, S. Y., Woo, D. G., Kim, M. S., & Park, K.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.008 · Cited by 80
Stinchcombe, T. E., Socinski, M. A., Walko, C. M., O’Neil, B. H., Collichio, F. A., Ivanova, A., Mu, H., Hawkins, M., Goldberg, R. M., Lindley, C. M., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0423-x · Cited by 79
Jan, T., Shen, Wang, C., & Liao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21019 · Cited by 79
Schweingruber, N., Haine, A., Tiede, K., Karabinskaya, A., van den Brandt, J., Wüst, S., Metselaar, J. M., Gold, R., Tuckermann, J. P., Reichardt, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101604 · Cited by 78
Product quality for nanomaterials: current U.S. experience and perspective
Tyner, K. M., Zou, P., Yang, X., Zhang, H., Cruz, C. N., & Lee, S. L. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1338 · Cited by 77
Moon, E., Yi, G.-H., Kang, J. S., Lim, J., Kim, H., & Pyo, S. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.543995 · Cited by 76
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
Vasievich, E. A., Chen, W., & Huang, L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0970-1 · Cited by 73
Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice
Inoue, K.-I., Takano, H., Yanagisawa, R., Hirano, S., Kobayashi, T., Fujitani, Y., Shimada, A., & Yoshikawa, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.022 · Cited by 69
Dendrimer-Induced Leukocyte Procoagulant Activity Depends on Particle Size and Surface Charge
Dobrovolskaia, M. A., Patri, A. K., Potter, T. M., Rodriguez, J. C., Hall, J. B., & McNeil, S. E. (2011) · Nanomedicine · doi:10.2217/nnm.11.105 · Cited by 69
Self-citationExtracellular entrapment and degradation of single-walled carbon nanotubes
Farrera, C., Bhattacharya, K., Lazzaretto, B., Andón, F. T., Hultenby, K. R., Kotchey, G. P., Star, A., & Fadeel, B. (2014) · Nanoscale · doi:10.1039/c3nr06047k · Cited by 69
Jeanbart, L., Kourtis, I. C., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1702-8 · Cited by 68
Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor
Nagayama, S., Ogawara, K., Minato, K., Fukuoka, Y., Takakura, Y., Hashida, M., Higaki, K., & Kimura, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.025 · Cited by 68
Yu, B., Mao, Y., Bai, L., Herman, S. E. M., Wang, X., Ramanunni, A., Jin, Y., Mo, X. M., Cheney, C. M., Chan, K. K., et al. (2012) · Blood · doi:10.1182/blood-2012-01-407742 · Cited by 67
Notch1 is involved in migration and invasion of human breast cancer cells
Gu, F. (2011) · Oncology Reports · doi:10.3892/or.2011.1399 · Cited by 67
Carpenter, J. P., Cherney, B., Lubinecki, A., Ma, S., Marszal, E., Mire‐Sluis, A. R., Nikolai, T. J., Novak, J. M., Ragheb, J. A., & Šimák, J. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.07.002 · Cited by 67
Shvedova, A. A., Tkach, A. V., Kisin, E. R., Khaliullin, T. O., Stanley, S., Gutkin, D. W., Star, A., Chen, Y., Shurin, G. V., Kagan, V. E., et al. (2012) · Small · doi:10.1002/smll.201201470 · Cited by 67
Self-citationAggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
Inoue, K., & Takano, H. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.44 · Cited by 64
van Beers, M. M. C., Gilli, F., Schellekens, H., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22744 · Cited by 64
Liu, Z., Li, W., Wang, F., Sun, C., Wang, L., Wang, J., & Sun, F. (2012) · Nanoscale · doi:10.1039/c2nr31355c · Cited by 64
Zheng, J. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.s5-001 · Cited by 63
Kim, S., Lim, K., Noh, J.-Y., Kim, K., Kang, S., Chang, Y. K., Shin, S., & Chung, J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr222 · Cited by 63
Vlasova, I. I., Vakhrusheva, T. V., Av, S., Kostevich, V. A., Gusev, A. A., Гусев, С. А., Melnikova, V. I., & Lobach, A. S. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.027 · Cited by 62
Promising particle-based vaccines in cancer therapy
Xiang, S. D., Scalzo‐Inguanti, K., Minigo, G., Park, A. J., Hardy, C. L., & Plebanski, M. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1103 · Cited by 61
Considerations When Submitting Nanotherapeutics to FDA/CDER for Regulatory Review
Tyner, K. M., & Sadrieh, N. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_3 · Cited by 57
Enzymatic ‘stripping’ and degradation of PEGylated carbon nanotubes
Bhattacharya, K., Sacchetti, C., El-Sayed, R., Fornara, A., Kotchey, G. P., Gaugler, J. A., Star, A., Bottini, M., & Fadeel, B. (2014) · Nanoscale · doi:10.1039/c4nr03604b · Cited by 57
Salvador-Morales, C., Basiuk, E. V., Basiuk, V. A., Green, M. L. H., & Sim, R. B. (2008) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2008.090 · Cited by 57
Shi, Y., Yadav, S. K., Wang, F., & Wang, H. (2010) · Journal of Toxicology and Environmental Health · doi:10.1080/15287391003614042 · Cited by 56
Boridy, S., Soliman, G. M., & Maysinger, D. (2012) · Nanomedicine · doi:10.2217/nnm.12.16 · Cited by 56
Umbreit, T. H., Francke‐Carroll, S., Weaver, J. L., et al. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1700 · Cited by 53
Ramani, K., Miclea, R. D., Purohit, V. S., Mager, D. E., Straubinger, R. M., & Balu‐Iyer, S. V. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21102 · Cited by 53
Jilek, S., Ulrich, M., Merkle, H. P., & Walter, E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033012.16152.5d · Cited by 53
Gaca, J. G., Palestrant, D., Lukes, D. J., Olausson, M., Parker, W., & Davis, R. D. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00142-2 · Cited by 50
Dobrovolskaia, M. A., & McNeil, S. E. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1014794 · Cited by 49
Self-citationDobrovolskaia, M. A., & McNeil, S. E. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1042857 · Cited by 46
Self-citationKlimuk, S. K., Semple, S. C., Nahirney, P. C., Mullen, M. C., Bennett, C. F., Scherrer, P., & Hope, M. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35316-9 · Cited by 46
Balenga, N. A. B., Zahedifard, F., Weiss, R., Sarbolouki, M. N., Thalhamer, J., & Rafati, S. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.014 · Cited by 46
Kim, J. Y., Choung, S., Lee, E., Kim, Y. J., & Choi, Y. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07335-1 · Cited by 45
Nano-Gold Corking and Enzymatic Uncorking of Carbon Nanotube Cups
Zhao, Y. J., Burkert, S. C., Tang, Y., Sorescu, D. C., Kapralov, A. A., Shurin, G. V., Shurin, M. R., Kagan, V. E., & Star, A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja511843w · Cited by 44
Self-citationGiacalone, G., Bochot, A., Fattal, E., & Hillaireau, H. (2013) · Biomacromolecules · doi:10.1021/bm301832v · Cited by 40
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases
Inoue, K. (2010) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-010-0177-7 · Cited by 39
Wegmann, K. W., Wagner, C. R., Whitham, R. H., & Hinrichs, D. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3301 · Cited by 37
THE INCREASED EFFICACY AND DECREASED NEPHROTOXICITY OF A CYCLOSPORINE LIPOSOME1,2
Freise, C. E., LIU, T., Hong, K., Osorio, R. W., Papahadjopoulos, D., Ferrell, L. D., Ascher, N. L., & Roberts, J. P. (1994) · Transplantation · doi:10.1097/00007890-199403270-00027 · Cited by 37
Targeted delivery systems for biological therapies of inflammatory diseases
Tran, T.-H., & Amiji, M. M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.972931 · Cited by 35
Ilinskaya, A. N., Clogston, J. D., McNeil, S. E., & Dobrovolskaia, M. A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.012 · Cited by 33
Self-citationAllergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis
Gómez, S., Gamazo, C., Román, B. S., Ferrer, M., Sanz, M. L., Espuelas, S., & Irache, J. M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.016 · Cited by 33
He, B., Cheng, M., Chen, H., Wang, Y., Xu, H., Han, J., & Zhang, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55255 · Cited by 30
Nanovaccines : nanocarriers for antigen delivery
González-Aramúndiz, J. V., Cordeiro, A. S., Csaba, N., de la Fuente, M., & Alonso, M. J. (2012) · Biologie Aujourd hui · doi:10.1051/jbio/2012027 · Cited by 29
Ilinskaya, A. N., Man, S., Patri, A. K., Clogston, J. D., Crist, R. M., Cachau, R. E., McNeil, S. E., & Dobrovolskaia, M. A. (2013) · Nanomedicine · doi:10.2217/nnm.13.137 · Cited by 27
Self-citationImmunological Properties of Engineered Nanomaterials: An Introduction
Dobrovolskaia, M. A., & McNeil, S. E. (2012) · Frontiers in nanobiomedical research · doi:10.1142/9789814390262_0001 · Cited by 27
Self-citationNanoparticles and modulation of immune responses
Pantic, I. V. (2011) · Science Progress · doi:10.3184/003685011x12979697342151 · Cited by 25
Walsh, M. C., Banas, J. A., Mudzinski, S. P., Preissler, M. T., Graziano, R. F., & Gosselin, E. J. (2002) · Biomolecular Engineering · doi:10.1016/s1389-0344(02)00089-8 · Cited by 21
Nanoparticles, Immunomodulation and Vaccine Delivery
Xiang, S. D., Fuchsberger, M., Karlson, T. D. L., Hardy, C. L., Selomulya, C., & Plebanski, M. (2012) · Frontiers in nanobiomedical research · doi:10.1142/9789814390262_0015 · Cited by 20
Cruz, C. N., Tyner, K. M., Velazquez, L., Hyams, K. C., Jacobs, A. C., Shaw, A. B., Jiang, W., Lionberger, R. A., Hinderling, P. H., Kong, Y., et al. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9466-6 · Cited by 18
Mathias, P. M., Harries, J. T., & Muller, D. P. R. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34754-4 · Cited by 18
Marx, V. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-729 · Cited by 17
Importance of Physicochemical Characterization Prior to Immunological Studies
Clogston, J. D., & Patri, A. K. (2016) · Frontiers in nanobiomedical research · doi:10.1142/9789813140431_0002 · Cited by 17
Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
Saad, A., & Lee, S. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4581 · Cited by 16
Seo, W., Kapralov, A. A., Shurin, G. V., Shurin, M. R., Kagan, V. E., & Star, A. (2015) · Nanoscale · doi:10.1039/c5nr00251f · Cited by 15
Self-citationBiagio, A. D., & Prinapori, R. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s88490 · Cited by 8
Cited by
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Self-citationToxicity of copper oxide nanoparticles: a review study
Naz, S., Gul, A., & Zia, M. (2020) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2019.0176 · Cited by 447
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Effects of engineered nanoparticles on the innate immune system
Liu, Y., Hardie, J., Zhang, X., & Rotello, V. M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.011 · Cited by 315
Metadata
- Authors
- Dobrovolskaia, M. A., Shurin, M., & Shvedova, A. A.
- Venue
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 299
- Pages
- 78-89
- ISSN
- 0041-008X (ISSN-L)
- OpenAlex
- W2212777275
- Cited by
- 309
- References
- 156
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.